BIOMAT Database Logo BIOMAT Database Logo

Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. 1988

I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Department of Biochemistry, Western Infirmary, Glasgow, Scotland.

In a prospective study designed to differentiate pheochromocytoma from other forms of hypertension, urinary catecholamines were measured after sleep and clonidine administration in 12 patients with pheochromocytoma, 19 hypertensive patients in whom pheochromocytoma was suspected but later excluded, and 31 hypertensive patients in whom pheochromocytoma was never suspected. The test correctly identified all 12 patients in whom pheochromocytoma was present. Four of these had equivocal plasma levels of both norepinephrine and epinephrine, suggesting that overnight clonidine suppression may be of particular value when tumor secretion is intermittent or low. When pheochromocytoma was not present, urinary norepinephrine and epinephrine levels were suppressed below 60 and 20 nmol/mmol creatinine, respectively, after sleep and clonidine, the two in combination giving better suppression than sleep alone. Since urinary catecholamines can be determined relatively easily by high-pressure liquid chromatography with electrochemical detection, this test may be more widely applicable than suppression tests based on plasma measurements.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000310 Adrenal Gland Neoplasms Tumors or cancer of the ADRENAL GLANDS. Adrenal Cancer,Adrenal Gland Cancer,Adrenal Neoplasm,Cancer of the Adrenal Gland,Neoplasms, Adrenal Gland,Adrenal Cancers,Adrenal Gland Cancers,Adrenal Gland Neoplasm,Adrenal Neoplasms,Cancer, Adrenal,Cancer, Adrenal Gland,Cancers, Adrenal,Cancers, Adrenal Gland,Neoplasm, Adrenal,Neoplasm, Adrenal Gland,Neoplasms, Adrenal

Related Publications

I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Clonidine-suppression test for diagnosis of pheochromocytoma.
January 1982, The New England journal of medicine,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Clonidine suppression test in pheochromocytoma.
July 1982, The New England journal of medicine,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
[The clonidine suppression test in pheochromocytoma].
September 1985, Orvosi hetilap,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.
September 1988, Klinische Wochenschrift,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Value of the clonidine suppression test in the diagnosis of pheochromocytoma.
January 1986, Acta medica Scandinavica. Supplementum,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.
September 1981, The New England journal of medicine,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
The value of the clonidine-suppression test in the diagnosis of pheochromocytoma.
October 1986, World journal of surgery,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Preliminary results with the clonidine suppression test in the diagnosis of pheochromocytoma.
January 1985, Cardiology,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
Complications of clonidine suppression test for pheochromocytoma.
September 1982, The New England journal of medicine,
I C Macdougall, and C G Isles, and H Stewart, and G C Inglis, and J Finlayson, and I Thomson, and K R Lees, and N C McMillan, and P Morley, and S G Ball
A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?
March 2008, Internal and emergency medicine,
Copied contents to your clipboard!